Sorbara EE

No ORCID on file · 1 paper in corpus
2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.808370

Given the importance of inflammation at the onset of multiple sclerosis (MS), therapy is mainly based on the use of anti-inflammatory drugs including disease modifying therapies (DMTs). Considering the recent approval of some DMTs, pharmaco…